Search by Drug Name or NDC
NDC 42023-0269-05 PREVDUO .2; 1 mg/mL; mg/mL Details
PREVDUO .2; 1 mg/mL; mg/mL
PREVDUO is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PAR PHARMACEUTICAL, INC.. The primary component is GLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE.
Product Information
| NDC | 42023-0269 |
|---|---|
| Product ID | 42023-269_dd8ad38f-247b-4948-a13c-8f3a4921b4f1 |
| Associated GPIs | |
| GCN Sequence Number | 084468 |
| GCN Sequence Number Description | glycopyrrolate/neostigmine SYRINGE 0.6-3 MG/3 INTRAVEN |
| HIC3 | J1B |
| HIC3 Description | CHOLINESTERASE INHIBITORS |
| GCN | 53792 |
| HICL Sequence Number | 006269 |
| HICL Sequence Number Description | GLYCOPYRROLATE/NEOSTIGMINE METHYLSULFATE |
| Brand/Generic | Brand |
| Proprietary Name | PREVDUO |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | neostigmine methylsulfate and glycopyrrolate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | .2; 1 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | GLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE |
| Labeler Name | PAR PHARMACEUTICAL, INC. |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA216903 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42023-0269-05 (42023026905)
| NDC Package Code | 42023-269-05 |
|---|---|
| Billing NDC | 42023026905 |
| Package | 5 SYRINGE, PLASTIC in 1 CARTON (42023-269-05) / 3 mL in 1 SYRINGE, PLASTIC (42023-269-01) |
| Marketing Start Date | 2023-05-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |